tiprankstipranks
Trending News
More News >
RxSight’s Market Challenges and Revised Growth Projections Lead to Hold Rating
PremiumRatingsRxSight’s Market Challenges and Revised Growth Projections Lead to Hold Rating
7d ago
RxSight’s Strategic Growth and Resilience Justify Buy Recommendation
Premium
Ratings
RxSight’s Strategic Growth and Resilience Justify Buy Recommendation
8d ago
RxSight price target lowered to $17 from $22 at Wells Fargo
Premium
The Fly
RxSight price target lowered to $17 from $22 at Wells Fargo
9d ago
RxSight downgraded to Underperform from Buy at BofA
PremiumThe FlyRxSight downgraded to Underperform from Buy at BofA
13d ago
RxSight’s Growth Potential Amid Challenges: A Buy Recommendation by David Saxon
Premium
Ratings
RxSight’s Growth Potential Amid Challenges: A Buy Recommendation by David Saxon
13d ago
RxSight’s Undervaluation and Growth Potential Justify Buy Rating Despite Revenue Shortfall
Premium
Ratings
RxSight’s Undervaluation and Growth Potential Justify Buy Rating Despite Revenue Shortfall
13d ago
BofA sees Bausch + Lomb IOL recall news as positive for RxSight
PremiumThe FlyBofA sees Bausch + Lomb IOL recall news as positive for RxSight
20d ago
Needham medtech & diagnostics analyst holds analyst/industry conference call
Premium
The Fly
Needham medtech & diagnostics analyst holds analyst/industry conference call
22d ago
RxSight price target lowered to $36 from $60 at BofA
Premium
The Fly
RxSight price target lowered to $36 from $60 at BofA
26d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100